In contrast to nonprimate species, the RNA for human tyrosine hydroxyl
ase, the rate-limiting enzyme in catecholamine biosynthesis, can under
go alternative splicing to produce four different types of mRNA. Altho
ugh types 1 and 2 of these human tyrosine hydroxylase mRNAs have been
identified in human brain, whether types 3 and 4 human tyrosine hydrox
ylase mRNAs are present in the central nervous system remains controve
rsial. Furthermore, little is known about the expression of the protei
n products of these mRNAs in human brain. In this study we used antibo
dies raised against different octapeptide sequences from each of the p
redicted human tyrosine hydroxylase protein forms to determine the pre
sence and distribution of each human tyrosine hydroxylase isoforms in
several regions of human brain. Control immunocytochemical and blot im
munolabeling experiments demonstrated that each antibody selectively r
ecognized the human tyrosine hydroxylase isoform against which it was
directed. In immunocytochemical studies, all four human tyrosine hydro
xylase isoforms were clearly detectable in neurons of both the substan
tia nigra and locus coeruleus. The presence of all four isoforms in th
ese nuclei was confirmed with blot immunolabeling studies. Single-labe
l immunocytochemical studies of adjacent sections as well as dual-labe
l comparisons of immunoreactivity for human tyrosine hydroxylase type
1 with type 2, type 3, or type 4 suggested that at least some neurons
in these brain regions contain all four human tyrosine hydroxylase iso
forms. In contrast, some neurons of the mesencephalon appeared to be s
electively immunoreactive with the antibodies against type 1. In the c
audate nucleus and putamen, the terminal zones of the dopaminergic pro
jection from the substantia nigra, all four isoforms were detected, al
though in immunocytochemical studies type 1 appeared to be the predomi
nant isoform present in axons and terminals. These findings demonstrat
e that human brain contains four distinct isoforms of human tyrosine h
ydroxylase and that the presence or relative amount of each isoform ma
y differ among catecholaminergic cell populations and between catechol
aminergic neurons and terminal fields. These patterns of expression ma
y have important implications for understanding the regulation of cate
cholamine biosynthesis in human brain both in normal and pathological
states.